Novartis AG/ US66987V1098 /
| 2024-04-15 9:59:58 PM | Chg. +0.86 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 94.40USD | +0.92% | 45,113 Turnover: 4.26 mill. |
-Bid Size: - | -Ask Size: - | 228.98 bill.USD | - | - |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.19 USD | -70.21% |
| EPS Diluted: | - USD | - |
| Revenues per Share: | - USD | - |
| Book Value per Share: | - USD | - |
| Cash Flow per Share: | - USD | - |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 50,545.00 USD | -2.09% |
| Net Income: | 6,955.00 USD | -71.04% |
| Operating Cash Flow: | 4,111.00 USD | - |
| Cash and Cash Equivalents: | 7,517.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | - | - |
| P/BV ratio: | - | - |
| P/CF Ratio: | - | - |
| PEG: | - | - |
| Earnings Yield: | - | - |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 228.98 bill. USD | 177.18 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | - | |
Profitability
| Gross Profit Margin: | 79.75% |
| EBIT Margin: | 18.20% |
| Net Profit Margin: | 13.76% |
| Return on Equity: | 11.70% |
| Return on Assets: | 5.92% |
Financial Strength
| Liquidity I / Cash Ratio: | 26.23% |
| Liquidity II / Quick Ratio: | 54.38% |
| Liquidity III / Current Ratio: | 128.80% |
| Debt / Equity Ratio: | 97.66% |
| Dynam. Debt / Equity Ratio: | 1,411.58% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2022-12-31 |
| Accounting Standard: | IFRS |
| Currency: | USD |
